Metropolitan Life Insurance Company »

Aerovate Therapeutics shares owned by Metropolitan Life Insurance Company

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Metropolitan Life Insurance Company from 13F filings

Historical chart of Metropolitan Life Insurance Company investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Metropolitan Life Insurance Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Metropolitan Life Insurance Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 701 22.63
2023-09-30 $9.5k 701 13.57
2023-06-30 $12k 701 17.15
2023-03-31 $14k 701 20.17
2022-12-31 $21k 701 29.30